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1. Introduction 
Pancreozymin (PZ) and muscarinic holinergic 
agents powerfully stimulate the secretion of pancre- 
atic hydrolases. Their mode of action is at the present 
time unclear, though Yransmembranous ionic move- 
ments involving primarily Ca2+ [1,2] , and cyclic AMP 
[3-51 have been implicated. However, the fact that 
calcium is involved [6] in ‘stimulus-secretion coup 
ling’ does not prove that this ion is a necessary medi- 
ator of emiocytosis. A pancreatic adepylatecyclase 
can be stimulated by pancreozymin [5,7,8] yet the 
status of cyclic AMP as a second messenger of the 
secretagogues is ambiguous. The occurrence in the 
rat pancreas of phosphodiesterase activity capable of 
hydrolyzing physiological concentrations of cyclic 
GMP [9] and of cyclic GMP-dependent protein 
kinase [lo] suggests hat cyclic GMP may intervene 
in pancreatic secretion. It was decided therefore to 
compare the in vivo time course of cyclic AMP and 
cyclic GMP levels following administration of pancreo- 
zymin, pilocarpine, secretin and vasoactive intestinal 
polypeptide (VIP). 
2. Materials and methods 
Male Wistar ats weighing 150-200 g were main- 
tained on a standard chow. In a fust series of experi- 
ments designed to investigate amylase secretion in 
response to pancreozymin and pilocarpine, the animals 
North-Holland fiblishing Company - Amsterdam 
were starved 24 hr and their pancreato-biliary duct 
was cannulated [ 111 under diethyl ether anesthesia. 
The animals were kept warm while the juice was col- 
lected over ice (fig. 1). 
A second series of experiments were undertaken to 
ascertain the time course of cyclic nucleotide levels. 
Animals receiving intravenous injections of pancreozy- 
min, secretin or VIP were fed ad libitum and were 
anesthetized with Nembutal. Animals receiving pilo- 
carpine subcutaneously were not anesthetized and 
were starved 24 hr. All of the animals were sacrificed 
by decapitation. The pancreas was dissected out as 
rapidly as possible, plunged into 5% CC 1 3 COOH and 
frozen at -7O’C. Later, the tissue was homogenized 
and centrifuged. Proteins in the precipitate were 
determined according to the method of Lowry et al. 
[ 141, using bovine albumin as a standard. The super- 
natant was acidified with HCl and CClsCOOH was 
eliminated by 5 successive extractions with diethyl 
ether. The residue obtained after lyophilization was 
dissolved in an appropriate volume of water. Cyclic 
AMP was estimated by the protein binding assay of 
Gilman [ 151. This method was valid in the 0.5-l 0.0 
pmoles range. In order to assay cyclic GMP, the vol- 
ume of supernatant which remained was loaded on 
Dowex AGI-X8 formate (0.7 X 3 cm) (Bio-Rad Lab., 
Richmond, Va., USA) and eluted, successively, with Hz( 
(5 ml), 3 N formic acid (9 ml) and 4.5 N formic acid 
(12 ml). The last fraction, containing all of the cy- 
clic GMP, was lyophilized. The cyclic nucleotide was 
determined by the radioimmunoassay of Steiner et 
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Fig. 1. (A) Secretion of amylase in response to pancreozymin. The pancreatobiliary juice was collected under diethyl ether anes- 
thesia. The first two 30-min samples allowed a study of basal output in U/l5 min. At time 60 min, seven rats received a single ad- 
ministration of pancreozymin (0.33 ng in 0.2 ml 0.9% NaCl corresponding to 5.5 Clin. U/kg) through a saphenous vein. The res- 
ponse was estimated on four 15-min samples. o-Amylase was estimated by the saccharogenic method of Noelting and Bernfeld 
[ 121 as automated by Vandermeers et al. [ 131. One unit is defined as the amount of amylase which liberates a reducing power 
equivalent o 1 pmole of maltose/mm at 25°C. (B) Secretory response following the injection of pilocarpine. The general condi- 
tions are the same as in A. The flow of amylase was estimated on two 30-min samples of juice, before, and eight 15-min samples 
after a subcutaneous injection of pilocarpine (30 mg/kg body weight). Each value represents the mean of 7 experiments. 
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radioactivity retained on the filter was estimated with a y 
counter. All determinations were made in duplicate. A linear 
01, , , 
.0125 .025 .05 .I0 .25 .50 1.0 2.5 5.0 10.0‘ 
relationship was observed between the % of radioactivity 
Unlabellod c GMP ( pmoles) 
remaining on the filter and the amount of unlabelled cyclic 
Fig. 2. Cyclic GMP standard curve obtained with a slight mc- 
GMP added (in log doses). The antiserum and the antigen 
(’ *$ I&GMP-TME) were from Collaborative Research Inc. 
difrcation of the method of Steiner et al. [ 161. ‘a51-S-cGMP- (W&ham, Mass., USA). 
al. [ 161, slightly modified. Fig. 2 illustrates a typical 
standard curve used for the determination of cyclic 
GMP in the 0.02-2.0 pmole range. Portions of repre- 
sentative samples of cyclic GMP purified by column 
TME (2000 cpm) was incubated for 3 hr at 4°C with the 
anti-cCMP serum and unlabelled cyclic GMP (0- 10 pmoles) 
in 0.05 M acetate buffer (pH 6.2). The amount of antibody 
allowed the binding of 45% of the radioactivity in the absen- 
ce of cold cyclic GMP. Free and bound antigen were se- 
parated by filtration on Millipore HAWP 0.45 r~ and the 
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Fig. 3. Comparison of the levels of cyclic AMP (A) and cyclic GMP (B) in response to pancreozymin. The animals were anestheti- 
zed with Nembutal(40 mg/kg, administered intraperitoneahy; Abbot Laboratories, Chicago, USA). Approximately 15 min later, 
they were injected through a saphenous vein with pancreozymin (0.33 ng in 0.2 ml 0.9% NaCl i.e. 5.5 Clin. U/kg: a) or with saline 
(0). Batches of six animals were killed at intervals of 1 min, 2 min, 5 min, 10 min and 15 min after the injection. Each value repre- 
sents mean of 6 determinations f SEM. 
chromatography were incubated with cyclic 3’,5”- 
phosphodiesterase before assay. The degradation of
the assayable cyclic GMP was essentially complete. 
Pilocarpine hydrochloride was obtained from 
Federa (Brussels, Belgium), pancreozymin, secretin 
and vasoactive intestinal polypeptide (VIP) were ob- 
tained from the GIH Research Unit of the Karolinska 
Institute (Stockholm, Sweden). 
3. Results and discussion 
The average in vivo pancreatic oncentration of 
cyclic AMP was 6.5 pmoles/mg protein (1.3 X 1 Oe6 Ml, 
assuming uniform distribution (fig. 4). A Nembutal 
anesthesia of approximately 30 min duration caused 
a progressive decrease in cyclic AMP to 3.0 pmoles/ 
mg protein (fig. 3). Pentobarbital nesthesia sknown 
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Fig. 4. Comparison of the levels of cyclic AMP (A) and cyclic GMP (B) in response to pilocarpine. The animals were conditioned 
for one week, being gently handled and receiving a daily subcutaneous injection of saline in order to minimize the stress due to 
injection when they received pilocarpine ( A: 30 mg/kg subcutaneously.) The controls (0) were also conditioned and were injected 
with saline only. Batches of six animals were kitled at intervals of 3,6, 12, 24 and 50 min after the injection. Each value represents 
mean of 6 determinations * SEM. 
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Fig. 5. Time course of variations in the levels of cyclic AMP in response to secretin (A) and VIP (B). Same general conditions as 
in fig. 3. The animals were anesthetized with Nembutal and were injected intravenously with secretin (2.75 &kg) or VIP (27.5 
&kg), in 0.2 ml 0.9% NaCl (A). The controls (0) were injected with saline only. Each value represents mean of 6 determinations 
iSEM. 
to increase certain amino acid levels [ 171 and to de- 
press protein synthesis [ 181 in the rat pancreas. All 
these effects may be due to inhibition of oxidative 
phosphorylation, reduction of visceral blood flow 
and/or to hypothermia. The average pancreatic yclic 
GMP concentration was 0.18 pmoles/mg protein, in 
vivo, only l/36 the average cyclic AMP concentra- 
tion. This control concentration was unaffected by 
Nembutal. 
The intravenous injection of pancreozymin caused 
a rapid increase in amylase secretion. Amylase output 
remained high at 30 min following injection, and de- 
clined to control values after 60 min (fig. 1A). The 
levels of cyclic AMP remained unchanged uring the 
15 min period following administration of pancreozy- 
min (fig. 3A). 
Figs. 1 B and 4B illustrate the secretory response 
and variations in the levels of cyclic AMP following 
the administration of pilocarpine. A dose capable of 
provoking a sustained hypersecretion of amylase cau- 
sed no apparent changes in the levels of cyclic AMP. 
Our data are at variance with the data of Case et al. 
[4] who reported a rapid rise (within 1 min) of cy 
clic AMP following the administration of pancreozy 
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min or acetylcholine in perfused cat pancreas. How- 
ever, there was no temporal relationship between cy- 
clic AMP levels and protein secretion in their experi- 
mental preparation, 
This stability of cyclic AMP we observed following 
the injection of these secretagogues was in marked 
contrast with the transient doubling of cyclic AMP 
following the intravenous injection of secretin (fig. 
SA) and VIP (fig. 5B), two hormones which elicit 
primarily the secretion of water and bicarbonate. 
Cyclic AMP levels showed a significant increase as 
early as the first time interval (30 to 60 set), and after 
reaching apeak, declined exponentially to the con- 
trol value in IO- 15 min. Our results upport he role 
of cyclic AMP as second messenger of secretin [191. 
They suggest also that the hormonal receptor sites of 
secretin and VIP are connected to the same adenylate 
cyclase [20] . 
Variations in pancreatic levels of cyclic GMP follow- 
ing the administration of pancreozymin or pilocar- 
pine are shown in figs. 3B and 4B. The level of cyclic 
GMP rose rapidly and markedly in the pancreas within 
1 to 3 min after injection dependi‘ng on the mode of 
administration (intravenous or subcutaneous). These 
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variations in the concentration of cyclic nucleotide 
were of shorter duration than the hypersecretory res- 
ponse: the levels of cyclic GMP exhibited a maximum 
2-fold increase at 5-6 min and decreased sharply 
thereafter, declining to control levels after about 
lo- 15 min. An elevation of cyclic GMP in response 
to acetylcholine has been observed in a number of 
tissues [21-241. Some polypeptide hormones uch 
as insulin in adipose cells [24] and the (Y and fl subu- 
nits of human chorionic gonadotropin in the ovary 
[25] exert similar effects. In the exocrine pancreas, 
it has been shown [26] that the stimulation of amy- 
lase secretion is associated with an increase in protein 
phosphorylation. This may be due in part to the rise 
of cyclic GMP. Indeed the pancreas contains a cyclic 
GMP-dependent protein kinase [IO]. To substantiate 
a role for cyclic GMP as a second messenger of both 
pancreozymin and cholinergic agents in acinar cells, 
it will be necessary to demonstrate he existence of 
a membranous guanylate cyclase responsive to both 
the polypeptide hormone and to the neurotransmit- 
ter. 
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